Dr. DeLoughery's Presentation - PowerPoint PPT Presentation

1 / 62
About This Presentation
Title:

Dr. DeLoughery's Presentation

Description:

Most patients with ITP have very low platelet counts ... www.pathy.med.nagoya-u.ac.jp/ atlas/doc/node114.html. Bone Marrow Testing ... – PowerPoint PPT presentation

Number of Views:58
Avg rating:3.0/5.0
Slides: 63
Provided by: Tom3111
Category:

less

Transcript and Presenter's Notes

Title: Dr. DeLoughery's Presentation


1
(No Transcript)
2
Immune Thrombocytopenia
  • 120,000
  • Autoimmune destruction of platelets
  • Patients present with very low platelet counts
  • Clinical history is diagnostic test
  • No other cause of thrombocytopenia
  • Normal blood smear

3
The Diagnosis ITP
  • Low platelets in an otherwise healthy person
    without an obvious other cause

4
(No Transcript)
5
Low Platelets
  • Most patients with ITP have very low platelet
    counts
  • Patient with moderate thrombocytopenia can be
    difficult to diagnosis
  • Liver disease
  • Congenital thrombocytopenia
  • Bone marrow problems

6
Otherwise Healthy
  • Other blood counts normal
  • Can be anemia due to blood loss
  • No other new problems
  • Kidney problems

7
No Other Obvious Cause
  • Drugs
  • New drugs in last 2 weeks
  • Infections
  • Bone marrow diseases

8
Fancy Tests
  • There is no test that can directly diagnose ITP

9
Testing
  • Anti-platelet antibodies
  • No helpful
  • Lupus testing
  • Thyroid testing

10
Blood Smear
  • Looking directly at the blood to see if anything
    is abnormal
  • Also to verify platelet count

11
www.pathy.med.nagoya-u.ac.jp/ atlas/doc/node114.ht
ml
12
(No Transcript)
13
Congenital Thrombocytopenia
  • Platelet counts 10-100,000
  • Clues
  • Family history of "ITP"
  • Very large platelets
  • Bleeding out of proportion to platelet count

14
www.pathy.med.nagoya-u.ac.jp/ atlas/doc/node114.ht
ml
15
Bone Marrow Testing
  • Not indicated if everything else fits
  • Indications
  • Platelets dont respond
  • Blood smear looks odd

16
Ultimate Test
  • If patient responds well to ITP therapy then they
    have ITP!

17
(No Transcript)
18
(No Transcript)
19
Therapy of ITP
20
Key Decisions in Treatment of ITP
  • Acute or Chronic
  • Bleeding or not bleeding
  • Fast or slow

21
Acute vs Chronic?
  • Initial presentation treated more aggressively
  • Long term patient therapy based on my experience
    with the patient

22
Bleeding or Not Bleeding?
  • Patients who are seriously bleeding get more
    aggressive treatment
  • Major stomach bleeding
  • Brain bleeding
  • Blood blisters in mouth

23
Fast or Slow?
  • How fast do you want the platelets up?
  • Fast
  • lt 10,000
  • Severe bleeding

24
(No Transcript)
25
Overview of Therapy
  • Prednisone
  • Dexamethasone
  • Methylprednisolone
  • Immune Globulin
  • Anti-D
  • Splenectomy
  • Rituximab
  • Cyclophosphamide
  • Azathioprine
  • Mycophenolate
  • Danazol
  • Vincristine
  • Dapsone
  • Interferon
  • Combined chemotherapy
  • Stem cell transplant
  • Neumega
  • AMG 531
  • Staph A column

26
ITP New Diagnosis
  • When to treat
  • What to treat with

27
When to treat
  • Guided by counts and bleeding
  • gt 50,000 - no therapy
  • lt 20,000 - some therapy
  • 20-50,000
  • Treat if bleeding, older, etc..

28
Initial Therapy
  • Steroids for all
  • IVIG or anti-D for very low counts or severe
    bleeding

29
Steroids
  • Decrease antibody production
  • Decrease splenic uptake of platelets
  • Increases platelet production
  • First line therapy
  • Prednisone 60 mg/day
  • Dexamethasone 40 mg/day for 4 days
  • May take up to a week to work
  • Rarely "cures" people

30
Steroids
  • Good
  • Cheap
  • Effective initially in most patients
  • Bad
  • Numerous side effects

31
Expected Response
  • Initial response 80-90
  • "Curative" response 10-30

32
Fast Therapy
  • Immune Globulin
  • Anti-D

33
Immune Globulin
  • Lots of theories on how IVIG works
  • 1 gram/kg x 2
  • Very effective in inducing rapid rise in
    platelets counts (lt24 hours)
  • Side effects
  • Large amounts of volume and time
  • Headaches
  • Thrombosis

34
Anti-D (WinRho)
  • "D" (aka Rh) is protein found on red cells in 85
    of the population
  • Spleen likes eating red cells more than platelets
  • One dose can rise platelet counts in less than 24
    hours
  • Cheaper, faster and safer than immune globulin
  • WinRho 75 ug/kg
  • Need spleen and to be Rh positive
  • Can decrease red cell count in some patients

35
Fast Therapy
  • Good
  • Fast
  • Effective (gt90)
  • Bad
  • Expensive
  • Anti-D cant be used in a lot of patients
  • Temporizing measure

36
(No Transcript)
37
Chronic ITP or Platelets are Low Again - Now What!
  • Most adults will get chronic disease
  • Absolutely no consensus on what to do

38
Splenectomy
  • Rates of splenectomy falling in USA
  • Many patients options for medical therapy
  • Acceptance of lower platelet counts as safe
  • gt 20-30,000 ok

39
Splenectomy
  • Removes site of platelet destruction
  • Removes site of antibody production
  • Initial response 85 of patients
  • "Cures" ITP 66 of time
  • Mortality much less than 1
  • Risk of overwhelming sepsis

40
When and If to do Splenectomy
  • Sooner
  • Counts lt 5-10,000
  • Patients desires
  • Patient otherwise healthy
  • Later
  • Counts 10-30,000
  • Patient desires
  • Poor health

41
Who Should do your Splenectomy
  • Laparoscopic method of choice
  • Surgeon should be experience with ITP patients

42
Splenectomy
  • Good
  • Curative in most patients
  • Bad
  • Not 100
  • Surgical complications
  • Prone to odd but severe infections

43
Infection
  • Patients without spleens are more prone to
    overwhelming sepsis
  • Risk is about 1500 and decreasing due to
    vaccinations
  • However, patients must be concerned if high
    fevers occur

44
(No Transcript)
45
Medical Therapy
  • Some patients will resolve ITP over months to
    years
  • Some patients may require minimal or infrequent
    therapy

46
Medical Therapy
  • IVIG or Anti-D
  • Longer courses of Dexamethasone
  • Danazol
  • Rituximab

47
Medical Therapy
  • Good
  • Some patients (30?) will avoid splenectomy or
    require infrequent therapy
  • Bad
  • Risk of bleeding if severely thrombocytopenic
  • Expensive
  • Side effects of therapy

48
(No Transcript)
49
Splenectomy Failures
  • Frustrating for all concerned
  • No ideal therapy
  • Treatments options are more aggressive as counts
    are lower

50
Options
  • Most patients
  • Rituximab
  • Danazol
  • lt 10,000
  • Azathioprine
  • Mycophenolate
  • lt 5,000
  • Pulse cyclophosphamide

51
(No Transcript)
52
Rituximab
  • Binds protein on lymphocyte called CD-20
  • Very effective in killing these cells
  • Developed 10 years ago as lymphoma therapy

53
Rituximab for ITP
  • Best therapy for splenectomy failures
  • Response rates of 60
  • Long term in 30 or so
  • May be higher?
  • Why it works unknown

54
Rituximab
  • Given weekly for 4 weeks total
  • Responses can take time
  • 1/3 - first week
  • 1/3 - first month
  • 1/3 - up to 4 months
  • Side effects
  • Shakes, chills
  • Rarely immune neutropenia

55
Rituximab
  • Good
  • Seems to be safe
  • Effective in most patients
  • Bad
  • No long term data
  • Unknown long term side effects

56
Why not Rituximab before Splenectomy
  • Appealing concept and widely done
  • However
  • Lower response rate
  • Spleen "sucks" up rituximab
  • Unknown long term side effects

57
Danazol
  • Weak male hormone that may impair uptake of
    antibody coated platelets
  • Need to use for up to 6 months to see effect
  • Can lead to weight gain, liver problems
  • Can be a effective and relatively safe therapy

58
Azathioprine and Mycophenolate
  • Weak immunosupressents
  • Relatively safe (can see low blood counts)
  • Takes time to work (4 months)

59
Pulse Cyclophosphamide
  • Large dose intravenous every month
  • Higher risk of nausea/vomit and low blood counts
  • Response rate is uncertain

60
Counts Low - Now What
  • Probably nothing works well
  • Might be best to leave most patients alone
  • "Therapy Roulette"
  • Otherwise refer for studies

61
Key Points
  • No standard set of therapy for all patients
  • Therapy tailored to patient
  • Patient choice important!

62
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com